Clinical trial / 2020
Collagen peptide supplementation for 12 weeks did not reduce knee pain or improve function more than placebo in active middle-aged and older adults.
A randomized controlled trial examined the effects of 10 g/day of collagen peptides (CP) versus placebo for 12 weeks in 167 physically active individuals with self-reported knee pain. Both groups experienced similar reductions in VAS pain scores (-1.6 ± 2.4 with CP vs. -1.9 ± 2.6 with placebo, p = 0.42). KOOS and Lysholm function scores increased significantly in both groups (p < 0.001), but the increases did not differ between groups (p = 0.28 and p = 0.76, respectively). CP also showed no effect on inflammatory, cartilage, or bone biomarkers (p > 0.05).
- Study type
- Randomized controlled trial
- Who was studied
- 167 healthy physically active individuals (median age 63 [IQR 56-68] years) with self-reported knee pain
- What was measured
- Knee pain (VAS), knee function (Lysholm, KOOS), and inflammatory, cartilage, and bone biomarkers
THE PAPER
Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain: a randomized controlled trial.
Bongers CCWG, Ten Haaf DSM, Catoire M, Kersten B, Wouters JA, Eijsvogels TMH, Hopman MTE. Appl Physiol Nutr Metab, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.